日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Osteosarcoma 3D patient derived cultures to test genome-informed personalized treatment options: a feasibility study

利用骨肉瘤患者来源的3D培养模型测试基因组指导下的个体化治疗方案:一项可行性研究

Palubeckaitė, Ieva; Venneker, Sanne; Franceschini, Natasja; Wijers-Koster, Pauline; Agaser, Cedrick; Briaire-de Bruijn, Inge; Kruisselbrink, Alwine B; van den Akker, Brendy; Mei, Hailiang; Cleton-Jansen, Anne-Marie; Gelderblom, Hans; van de Sande, Michiel A J; Bovée, Judith V M G

A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target

启动骨肉瘤发生事件的小鼠间充质干细胞模型表明 CDK4/CDK6 抑制是治疗靶点

Natasja Franceschini, Raffaele Gaeta, Paul Krimpenfort, Inge Briaire-de Bruijn, Alwine B Kruisselbrink, Karoly Szuhai, Ieva Palubeckaitė, Anne-Marie Cleton-Jansen, Judith V M G Bovée

Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of Bone

组蛋白去乙酰化酶抑制剂作为消除骨巨细胞瘤中肿瘤“基质”细胞的治疗策略

Sanne Venneker, Robin van Eenige, Alwine B Kruisselbrink, Ieva Palubeckaitė, Alice E Taliento, Inge H Briaire-de Bruijn, Pancras C W Hogendoorn, Michiel A J van de Sande, Hans Gelderblom, Hailiang Mei, Judith V M G Bovée, Karoly Szuhai

Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression

以 NAD 补救合成途径为目标作为低 NAPRT 表达的骨肉瘤的新型治疗策略

Natasja Franceschini, Jan Oosting, Maud Tamsma, Bertine Niessen, Inge Briaire-de Bruijn, Brendy van den Akker, Alwine B Kruisselbrink, Ieva Palubeckaitė, Judith V M G Bovée, Anne-Marie Cleton-Jansen

SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone

SUMO化与骨软骨肉瘤的侵袭性行为相关

Jessie S Kroonen, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, Olaejirinde O Olaofe, Judith V M G Bovée, Alfred C O Vertegaal

Transformed Canine and Murine Mesenchymal Stem Cells as a Model for Sarcoma with Complex Genomics

转化犬和鼠间充质干细胞作为具有复杂基因组的肉瘤模型

Natasja Franceschini, Bas Verbruggen, Marianna A Tryfonidou, Alwine B Kruisselbrink, Hans Baelde, Karin E de Visser, Karoly Szuhai, Anne-Marie Cleton-Jansen, Judith V M G Bovée

Beyond the Influence of IDH Mutations: Exploring Epigenetic Vulnerabilities in Chondrosarcoma

超越 IDH 突变的影响:探索软骨肉瘤的表观遗传弱点

Sanne Venneker, Alwine B Kruisselbrink, Zuzanna Baranski, Ieva Palubeckaite, Inge H Briaire-de Bruijn, Jan Oosting, Pim J French, Erik H J Danen, Judith V M G Bovée

Exploration of the chondrosarcoma metabolome; the mTOR pathway as an important pro-survival pathway

探索软骨肉瘤代谢组;mTOR 通路作为重要的促生存通路

Ruben D Addie, Yvonne de Jong, Gaia Alberti, Alwine B Kruisselbrink, Ivo Que, Hans Baelde, Judith V M G Bovée

Radiotherapy resistance in chondrosarcoma cells; a possible correlation with alterations in cell cycle related genes

软骨肉瘤细胞的放射治疗抗性;可能与细胞周期相关基因的改变有关

Yvonne de Jong, Martha Ingola, Inge H Briaire-de Bruijn, Alwine B Kruisselbrink, Sanne Venneker, Ieva Palubeckaite, Bram P A M Heijs, Anne-Marie Cleton-Jansen, Rick L M Haas, Judith V M G Bovée

Inhibition of PARP Sensitizes Chondrosarcoma Cell Lines to Chemo- and Radiotherapy Irrespective of the IDH1 or IDH2 Mutation Status

无论 IDH1 或 IDH2 突变状态如何,PARP 抑制均可增强软骨肉瘤细胞系对化疗和放疗的敏感性

Sanne Venneker, Alwine B Kruisselbrink, Inge H Briaire-de Bruijn, Yvonne de Jong, Andre J van Wijnen, Erik H J Danen, Judith V M G Bovée